Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haake

Showing results (701-710 of 812) with videos related to

Pageof 82
Sort By:
Human Mutation|August 3, 2022
Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoformGuy Helman, Asako Takanohashi, Tracy L Hagemann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 10, 2008
[Oral candidiasis]Dieter Reinel, Andreas Plettenberg, Claus Seebacher, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 21, 2006
Tinea capitisClaus Seebacher, Dietrich Abeck, Jochen Brasch, et al.
Annals of Intensive Care|July 20, 2016
Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysisFranziska C Trudzinski, Peter Minko, Daniel Rapp, et al.
Oncotarget|February 25, 2016
Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repairMichael P Croglio, Jefferson M Haake, Colin P Ryan, et al.
Plos Pathogens|January 7, 2026
cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in miceSuman Gupta, James Matsunaga, Bridget Ratitong, et al.
Stem Cell Reports|December 19, 2017
Impaired IFNγ-Signaling and Mycobacterial Clearance in IFNγR1-Deficient Human iPSC-Derived MacrophagesAnna-Lena Neehus, Jenny Lam, Kathrin Haake, et al.
Intensive Care Medicine|January 13, 2016
Escalation of therapy without evidence: a "may" does not imply a "should"!M Heringlake, B Bein, M Buerke, et al.
Nature Communications|December 4, 2018
Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infectionsMania Ackermann, Henning Kempf, Miriam Hetzel, et al.
Nature Immunology|March 29, 2001
Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanismC Werts, R I Tapping, J C Mathison, et al.
Pageof 82

Showing results (701-710 of 812) with videos related to

Sort By:
Pageof 82
Human Mutation|August 3, 2022
Type II Alexander disease caused by splicing errors and aberrant overexpression of an uncharacterized GFAP isoformGuy Helman, Asako Takanohashi, Tracy L Hagemann, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 10, 2008
[Oral candidiasis]Dieter Reinel, Andreas Plettenberg, Claus Seebacher, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|December 21, 2006
Tinea capitisClaus Seebacher, Dietrich Abeck, Jochen Brasch, et al.
Annals of Intensive Care|July 20, 2016
Runtime and aPTT predict venous thrombosis and thromboembolism in patients on extracorporeal membrane oxygenation: a retrospective analysisFranziska C Trudzinski, Peter Minko, Daniel Rapp, et al.
Oncotarget|February 25, 2016
Analogs of the novel phytohormone, strigolactone, trigger apoptosis and synergize with PARP inhibitors by inducing DNA damage and inhibiting DNA repairMichael P Croglio, Jefferson M Haake, Colin P Ryan, et al.
Plos Pathogens|January 7, 2026
cGAS-STING dependent type I IFN reduces Leptospira interrogans renal colonization in miceSuman Gupta, James Matsunaga, Bridget Ratitong, et al.
Stem Cell Reports|December 19, 2017
Impaired IFNγ-Signaling and Mycobacterial Clearance in IFNγR1-Deficient Human iPSC-Derived MacrophagesAnna-Lena Neehus, Jenny Lam, Kathrin Haake, et al.
Intensive Care Medicine|January 13, 2016
Escalation of therapy without evidence: a "may" does not imply a "should"!M Heringlake, B Bein, M Buerke, et al.
Nature Communications|December 4, 2018
Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infectionsMania Ackermann, Henning Kempf, Miriam Hetzel, et al.
Nature Immunology|March 29, 2001
Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanismC Werts, R I Tapping, J C Mathison, et al.
Pageof 82